Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,741 JPY | -3.96% | +1.14% | 0.00% |
03:25am | Actinogen Medical Raising Up to AU$8.9 Million for Advancing Trial, Working Capital; Shares Fall 24% | MT |
May. 02 | Judge in Trump hush-money trial weighs further fines | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.11B | |
+10.99% | 325B | |
+11.02% | 73.15B | |
-6.58% | 65.82B | |
+0.88% | 30.13B | |
+20.71% | 23.36B | |
+9.66% | 14.31B | |
+12.87% | 10B | |
+20.37% | 9.39B | |
-1.67% | 4.58B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy